-activated potassium channels known to interact with calmodulin, such as 1-EBIO, DCEBIO, or riluzole, also activated TMEM16A. These results reinforce the use of these compounds for activation of electrolyte secretion in diseases such as cystic fibrosis.-Tian, Y., Kongsuphol, P., Hug, M., Ousingsawat, J., Witzgall, R., Schreiber, R., Kunzelmann, K. Calmodulin-dependent activation of the epithelial calcium-dependent chloride channel TMEM16A. FASEB J. 25, 1058-1068 (2011). www.fasebj.org
-activated Cl
Ϫ channels ⅐ anoctamin 1 ⅐ exocytosis ⅐ SK4 ⅐ 1-EBIO ⅐ cystic fibrosis Broadly expressed Ca 2ϩ -activated Cl Ϫ channels (CaCCs) are of fundamental importance in many tissues, as they control electrolyte secretion, neuronal excitability, and smooth muscle contraction. CaCCs have been identified as TMEM16A (1) (2) (3) . TMEM16A (anoctamin 1, ANO1) belongs to a family of 10 TMEM16-proteins (TMEM16A-K, . TMEM16A has 8 putative transmembrane domains (TMDs) and a p-loop between TMD 5 and TMD 6. Along with multiple splice variants, several isoforms are coexpressed in a tissue-specific manner, which provides a Ca 2ϩ -activated Cl Ϫ conductance of distinct biophysical and pharmacological features (4, 5) . It has been shown that alternative splicing of TMEM16A changes voltage dependence and Ca 2ϩ sensitivity (4) . Moreover, membrane expression, time dependence and amplitude of the current, Ca 2ϩ dependence, and sensitivity toward inhibitors vary among TMEM16 proteins. Preliminary data suggest that these proteins can exist as heterooligomeric complexes (6) . TMEM16A shows common characteristics of the native CaCCs, present in a large number of tissues and cell types (1-3, 7, 8) . We and others demonstrated the fundamental importance of TMEM16A for Ca 2ϩ -dependent Cl Ϫ secretion in a number of epithelial tissues (9) (10) (11) . TMEM16A is essential for Ca 2ϩ -dependent Cl Ϫ currents in airways, large intestine, salivary gland, pancreatic gland, and hepatocytes (9) (10) (11) . Severe transport defects were detected in epithelial tissues of TMEM16A-knockout mice, leading to reduced saliva production and attenuated mucociliary clearance of the airways (9, 10, 12) . Thus, TMEM16A is essential for proper development and hydration of the airways (13) . Knockout animals die early because of unstable airways and because they cannot digest and absorb food. The outstanding physiological significance of TMEM16A is further supported by its role in pacemaker cells, where it controls smooth muscle contraction, and by its contribution to generation of acute nociceptive signals (3, (14) (15) (16) (17) . Moreover, TMEM16A does also participate in fundamental cellular mechanisms, such as regulation of the cell volume, and it interferes with Escherichia coli ␣-hemolysin-induced shrinkage of erythrocytes and subsequent hemolysis (18, 19) .
Although it is clear that TMEM16A produces Cl Ϫ currents on increase in [Ca 2ϩ ]i, it is not known whether [Ca 2ϩ ]i binds directly to the channel. A string of negatively charged glutamic acid residues in the first intracellular loop could form a Ca 2ϩ binding pocket, but its role for Ca 2ϩ binding remains unclear (20) . The available data do not explain the mechanism for activation of TMEM16A by Ca 2ϩ and whether phosphorylation or membrane trafficking is required. Here, we elucidated the mechanisms for activation of TMEM16A and found that both ATP and calmodulin are required. The present results suggest a regulation of TMEM16A similar to that of 1 These authors contributed equally to this work. -activated K ϩ (SK) channels. Also, both types of channels share pharmacological properties (21) . Understanding the regulation of TMEM16A will allow the development of novel classes of pharmaceutical compounds, such as benzimidazolinones. Because both Ca 2ϩ -dependent K ϩ and Cl Ϫ channels are expressed in human airways, in contrast to adult human colon, which does not express Ca 2ϩ -activated Cl Ϫ channels, benzimidazolinones are promising tools to reinstall Cl Ϫ secretion in airways in cystic fibrosis (CF).
MATERIALS AND METHODS
Cell culture, cDNAs, and transfection HEK 293 and Calu-3 cells were grown in DMEM (Gibco, Karlsruhe, Germany) supplemented with 10% FBS at 37°C in a humidified atmosphere with 5% CO 2 . Cells were plated on fibronectin-and collagen-coated coverslips and cotransfected with cDNA encoding either mTMEM16A, hTMEM16A, hSK4, or empty pcDNA3.1 vector (mock) along with P2Y 2 receptor and CD8. Transfections were carried out using Lipofectamine 2000 (Invitrogen, Karlsruhe, Germany) according to the manufacturer's protocol.
Patch clamping
At 2 or 3 d after transfection, transfected cells were identified by incubating the cells 1-2 min with Dynabeads CD8 (Invitrogen). Coverslips were mounted on the stage of an inverted microscope (IM35; Carl Zeiss, Jena, Germany) and kept at 37°C. The bath was perfused continuously with Ringer solution at the rate of 5 ml/min. For fast whole-cell patch clamping, pipettes were filled with intracellular-like "physiological" solution containing 30 mM KCl, 95 mM potassium gluconate, 1.2 mM NaH 2 PO 4 , 4.8 mM Na 2 HPO 4 , 1 mM EGTA, 0.758 mM calcium gluconate, 1.034 mM MgCl 2 , 5 mM d-glucose, and 3 mM ATP (pH 7.2), with an input resistance of 2-4 M⍀. Experiments were conducted as described earlier (9) .
Ussing chamber experiments
After isolation, mouse tracheas were immediately put into ice-cold buffer solution. Tracheas were opened longitudinally and mounted into a perfused micro-Ussing chamber with a circular aperture and a diameter of 0.95 mm. Luminal and basolateral sides of the epithelium were perfused continuously at a rate of 5 ml/min with solution containing 145 mM NaCl, 0.4 mM KH 2 PO 4 , 1.6 mM K 2 HPO 4 , 5 mM d-glucose, 1 mM MgCl 2 , 5 mM HEPES, and 1.3 mM Ca gluconate (pH 7.4) that was heated to 37°C. Experiments were carried out under open-circuit conditions. Values for transepithelial voltages (V te ) were referred to the serosal side of the epithelium. Transepithelial resistance (R te ) was determined by applying short (1 s) current pulses (⌬lϭ0.5 A) and after subtracting the resistance of the empty chamber using Ohm's law.
ReAsH labeling and electron microscopy
HEK293 or COS-7 cells were transiently transfected using DEAE dextran/chloroquine (22) . After 3 d, cells were incubated for 1 h at 37°C with 450 nM resorufin arsenical hairpin binding reagent (ReAsH; Invitrogen) and 12.5 M 1,2-ethanedithiol (EDT; Fluka, Buchs, Switzerland); the cells were then washed twice briefly with 500 nM 2,3-dimercapto-1-propanol (BAL; Fluka), incubated in 500 nM BAL for 20 min at 37°C, washed again 3 times with HBSS, and fixed with 2% glutaraldehyde overnight. Cells were blocked for 30 min in 50 mM glycine, 10 mM KCN, 20 mM aminotriazole, and 0.001% H 2 O 2 , and were washed with new buffer containing 1 mg/ml of diaminobenzidine. Photoconversion was performed by exposing the cells at 4°C to a 585-nm light source. Finally, the cells were washed again and embedded in Durcupan (Fluka). Thin sections (50 nm) were analyzed in a Zeiss EM 902 transmission electron microscope equipped with a cooled CCD digital camera (TRS, Moorenweis, Germany).
Western blot analysis, immunoprecipitation
Protein was isolated from transfected HEK293 cells in lysis buffer containing 50 mM Tris-HCl, 150 mM NaCl, 100 mM DTT, 0.2% Triton X-100, 5 U/ml of benzonase, and 1% protease inhibitor cocktail (Sigma-Aldrich, Taufkirchen, Germany). Prior to the addition of 1-5 g of the primary antibody, protein lysates were precleared with protein A agarose beads (Pierce, Rockford, IL, USA). Incubation with primary antibodies was performed 3 h at 4°C, and the protein-antibody complex was immobilized by the addition of 25 l of protein A agarose beads for 1 h at 4°C. The beads were washed in PBS, and then boiled in 1ϫ loading sample buffer for Western blot analysis using 10% SDS-PAGE. The protein was transferred to a polyvinylidene difluoride membrane (GE Healthcare, Munich, Germany) using semidry transfer (Bio-Rad, Munich, Germany). Membranes were incubated with first antibodies (dilution from 1:500 to 1:1000) overnight at 4°C. Proteins were visualized using a horseradish peroxidase (HRP)-conjugated secondary antibody (dilution 1:10,000) and ECL detection kit (GE Healthcare); the protein bands were detected by FujiFilm LAS-3000 (FujiFilm, Tokyo, Japan).
Immunocytochemistry
HEK293 cells were grown on glass coverslips and washed 3 times in PBS. Cells were fixed with methanol at Ϫ20°C for 5 min and incubated with primary antibodies at 4°C overnight. Monoclonal rabbit anti-mouse TMEM16A antibody was used as first antibody. For immunofluorescence, cells were incubated with secondary AlexaFluor 488 goat anti-rabbit IgG for 1 h at room temperature and counterstained with Hoe33342 (Sigma-Aldrich). Immunofluorescence was detected using an Axiovert 200 microscope equipped with an ApoTome and AxioVision software (Carl Zeiss).
Materials and statistical analysis
All compounds [ionomycin, 1-ethyl-2-benzimidazolinone (1-EBIO), riluzole, cytochalasin D, BIM, dynasore, okadaic acid, phalloidin, STO-609, KN93, KN62, KT5720, IBMX, forskolin, trifluoroperazine, calmodulin, ATP, BAPTA-AM, U0126, apyrase, and dasatinib] were from Sigma-Aldrich or Merck (Darmstadt, Germany). Peptides were synthesized by Davids Biotechnologie (Regensburg, Germany); sequences are as follows: CAM-BD 1, NH 2 -VRKYFGEKVGLYFA-COOH; CAM-BD 2, NH 2 -LLSKRRKCGKYGITSLLA-COOH. AO1 was generously provided by Sygnature Chemical Services Ltd. (Nottingham, UK). The anti-hTMEM16A was a generous gift from Prof. van de Rijn (Department of Pathology, Stanford University, Stanford, CA, USA). All cell culture reagents were from Gibco/Invitrogen. Student's t test (for paired or unpaired samples as appropriate) and ANOVA were used for statistical analysis. Values of P Ͻ 0.05 were accepted as significant.
RESULTS

TMEM16A is strictly membrane localized and is regulated by cytoskeletal components
It is believed that Ca 2ϩ -dependent Cl Ϫ currents are activated through an increase in intracellular Ca 2ϩ and binding to TMEM16A or an associated protein. However, this has not been proven, and alternatively, the current may be activated by exocytosis of TMEM16A and insertion into the plasma membrane. This has been proposed for the exocrine pancreas (23) . We examined localization of TMEM16A when overexpressed in HEK293 and Cos-7 cells, using immunocytochemistry and electron microscopy. TMEM16A appeared clearly membrane localized in immunohistochemistry of HEK293 cells (Fig. 1A) . This was confirmed by highresolution electron microscopy using ReAsH labeling (see Materials and Methods). The images clearly indicate a strict membrane localization of TMEM16A in overexpressing HEK293 cells (Fig. 1B) . No ReAsH labeling was observed in mock-transfected control cells (Fig. 1C ). Similar staining was observed in Cos-7 cells after expression of TMEM16A (Supplemental Fig. S1 ).
Activation of TMEM16A in HEK293 cells was examined using whole-cell patch-clamp recordings. We expressed both human and mouse TMEM16A, which produced similar whole-cell Cl Ϫ conductances. While no currents were observed in HEK293 control cells, large whole-cell Cl Ϫ currents were activated by the Ca 2ϩ ionophore ionomycin (1 M) in TMEM16A-expressing cells ( Fig. 1D, E) . Notably, whole-cell baseline currents were enhanced in TMEM16A-expressing cells, even in the absence of ionomycin, and both enhanced baseline conductance and ionomycin-activated conductance were inhibited by 10 M AO1, a specific inhibitor of Ca 2ϩ -activated Cl Ϫ currents (24) (Fig. 1G) . Interestingly, activation of currents was suppressed by depolymerizing or stabilizing actin with cytochalasin D and phalloidin, respectively (Fig. 1F, G) . Maneuvers that inhibit exocytosis or endocytosis (10 M dynasore; 10 M calmodulindependent kinase inhibitor STO-609; siRNA for synapsin 1) had no effect (data not shown). Thus, membranelocalized TMEM16A is activated by Ca 2ϩ in an actindependent manner.
Phosphorylation is not a prerequisite for activation of TMEM16A
As reported earlier, intracellular N and C termini of TMEM6A carry a number of sites with consensus sequences for phosphorylation by protein kinases, such as protein kinase A (PKA), protein kinase C (PKC), calmodulin-dependent kinase (CAMK), casein kinase 2 (CK2), and extracellular regulated kinase 1,2 (Erk1,2) (5). Moreover, the present results and a previous study suggest that cytosolic ATP is required for full activation of TMEM16A (18) . Activation of TMEM16A by ionomycin (1 M) or stimulation of P2Y receptors with ATP (100 M) was unaffected in the presence of an ATP-free pipette filling solution (⌬G Iono ϭ45Ϯ5.2 nS; ⌬G ATP ϭ50Ϯ5.7 nS), but it was abolished with apyrase (2 U/ml) in the patch pipette ( Fig. 2A-E) . This suggests that cytosolic ATP is required for complete activation of TMEM16A, and it could be required for phosphorylation of the channel. Therefore, we applied ionomycin after inhibition of various kinases for which potential phosphorylation sides have been detected in TMEM16A. Cells were stimulated in the presence of inhibitors of CAMKII (KN93, KN62), PKC (BIM), PKA (KT5720), or CK2 (TBB), or in the presence of IBMX and forskolin, which increase intracellular cAMP (Fig. 2B) . None of these treatments changed activation of TMEM16A by ionomycin. In contrast, the CAMKII inhibitor KN62 even augmented Ca 2ϩ -activated Cl Ϫ currents, similar to what has been reported for smooth muscle cells (25, 26) . Moreover, the broad nonspecific kinase inhibitor staurosporine (5 M, 2 h) and the phosphatase 2A inhibitor okadaic acid (10 nM, 2 h) had no effect on channel activation (data not shown). All inhibitors used in the present study have been demonstrated to exert their expected actions at the concentrations used in the present report: KN63 inhibited CaCCs in CFPAC cells; BIM prevented the epithelial Na ϩ channel ENaC from inhibition by PKC; KT5720 and TBB inhibited activation of CFTR; and U0126 attenuated P2Y 2 -induced inhibition of ENaC. Finally, siRNA knockdown of CAMKII␥ and CK2 did not inhibit TMEM16A (data not shown).
Expression of the double-mutant S967A/S970A-TMEM16A (Erk1,2-mut) that lacks two consensus sequences for Erk1,2 in the C terminus did not change activation of TMEM16A by ionomycin but reduced receptor-mediated activation by ATP (10 M) (Fig. 2C, F) . Since the MEK inhibitor U0126 did not inhibit receptordependent activation of TMEM16A, stimulation of P2Y 2 receptors may activate Erk1,2 and TMEM16A in a MEKindependent manner, (18, 27) . Nonetheless, Erk1,2 phosphorylation is not absolutely essential for channel activation, as high [Ca 2ϩ ] i levels (application of ionomycin) activate TMEM16a in an Erk1,2-independent fashion. Typically, ion channels that are regulated by calmodulin and the cytoskeleton are often controlled by phosphatidylinositols, such as PIP 3 and PIP 2 (28) . However, we found that neither siRNA knockdown of the phosphatase and tensin homologue (PTEN), which hydrolyzes PIP 3 to PIP 2 , nor inhibition of the PI3-kinase by wortmannin (1 M; nϭ8) compromised activation of TMEM16A by ionomycin (data not shown). Thus, it remains unclear how ATP is involved in regulation of TMEM16A.
Calmodulin is essential for activation of TMEM16A
A number of studies report activation of endogenous Ca 2ϩ -dependent Cl Ϫ currents by CAMKII (8, 29 -31) , However, we did not find that CAMKII is essential for activation of TMEM16A overexpressed in HEK 293 cells (Fig. 2) . In contrast, when calmodulin was inhibited by trifluoperazine (10 M) or the highly specific inhibitor J-8 (50 M), activation of TMEM16A by both ionomycin and ATP was largely suppressed (Fig. 3) . This calmodulin and ATP dependence of TMEM16A is reminiscent of Ca 2ϩ -dependent KCNN4 potassium channels, which also require both factors for complete activation (32) (33) (34) . Calmodulin binds to the intracellular C terminus of KCNN4 channel and acts as a Ca 2ϩ sensor to control channel assembly and surface expression of KCNN4 (35) .
Using a Web-based prediction program (Calmodulin Target Database; Mitsu Ikura Laboratory, Ontario Cancer Institute, University of Toronto, Toronto, ON, Canada), we identified two putative calmodulin binding domains (CAM-BD1, CAM-BD2) located in the intracellular N terminus of TMEM16A (Fig. 4A) . In fact, calmodulin could be coimmunoprecipitated using a TMEM16A antibody, while TMEM16A was coimmunoprecipitated by a CAM antibody in lysates from TMEM16A-expressing cells (Fig. 4B) . No coimmunoprecipitation was observed with protein A agarose beads only. TMEM16A is expressed in different splice forms, which are characterized by amino acid inserts (segments a-d) in the N terminus and the intracellular loop (Fig. 4A) (1). The putative CAM-BD1 overlaps with segment b of the splice form abc-TMEM16A. We expressed the different splice forms in HEK293 cells; however, coimmunoprecipitation and detection by Western blot were unsuccessful with ac-TMEM16 (data not shown), although ac-TMEM16A and abc-TMEM16A are comparably expressed at the plasma membrane (Supplemental Fig. S2B ). To further examine the role of these putative calmodulin binding domains, we perfused the cytosol via the patch pipette with short peptides corresponding to the sequences of CAM-BD1 and CAM-BD2. In the presence of CAM-BP1, activation by ionomycin of human and mouse TMEM16A was inhibited, while CAM-BP2 had no effect (Fig. 4C-E) . These results suggest that CAM-BP1 may bind to calmodulin, thereby interfering with activation of TMEM16A.
Further attempts to confirm interaction of CAM with the N terminus of TMEM16A were unsuccessful, since 2 N-terminal truncations of TMEM16A (M266-16A and M350-16A) annihilated membrane expres- sion of the protein ( Fig. 4F and Supplemental Fig  2A) . Notably, truncation of the C terminus had no effect on channel activation by ionomycin, but attenuated receptor-mediated activation by ATP, probably due to elimination of the Erk1,2 sites (Fig. 4F, G) . When we expressed the splice form ac-TMEM16A, we found that a Cl Ϫ current was still activated by ionomycin, albeit the whole-cell conductance was slightly attenuated when compared to abc-TMEM16A. Thus, the putative CAM-BD1 supports Ca 2ϩ -dependent activation of the channel, but it is not essential for the function of TMEM16A (Fig. 4F) .
TMEM16A requires Ca
2؉ , ATP, and calmodulin for full activation
In cell-attached patches of TMEM16A-expressing HEK293 cells, we detected activation of current noise after purinergic stimulation with ATP, which was not observed in control (mock-transfected) cells (Fig. 5A) . However, we were unable to resolve single-channel activity, probably due to the very small single-channel conductance. When membrane patches were excised inside-out after stimulation of TMEM16A-expressing cells, the channel noise disappeared within seconds, and removal of Ca 2ϩ from the bath (cytosolic side) had no effect (Fig. 5B, top trace) . In contrast to TMEM16A, Ca 2ϩ -dependent K ϩ channels (KCNN4, SK4) were readily detectable in excised insideout patches and were inhibited by removal of cytosolic Ca 2ϩ (Fig. 5B, bottom trace) . We measured the conductance of excised membrane patches from ATP-stimulated and TMEM16A-expressing cells immediately after excision, and 1 or 2 min after removal from the whole cell. When excised into Ca 2ϩ -free Ringer solution, the membrane conductance of the patch was small right after excision (Fig. 5C) . In contrast, when excised into a Ca 2ϩ -containing Ringer solution, an outwardly rectifying current was detected that inactivated within a minute after excision, suggesting rapid rundown of TMEM16A currents (Fig. 5D) . We speculated that cytosolic factors, such as ATP or calmodulin, might get lost during membrane excision and therefore added ATP (3 mM) to the bath solution (cytosolic side), which increased the current noise and slightly enhanced the conductance of patches from TMEM16A-expressing cells, but not from mock-transfected cells (Fig. 6) . Further addition of calmodulin (1 g/ml) increased the channel noise and activated a membrane conductance in patches from TMEM16A-expressing cells but not from control cells. Thus ATP and calmodulin may be required to keep TMEM16A channels active (Fig. 6 ).
TMEM16A and SK4 share pharmacological properties
Benzimidazolinones such as 1-EBIO are well-known activators of Ca 2ϩ -dependent K ϩ channels and enhance the affinity of K ϩ channels for Ca 2ϩ /calmodulin (36, 37) . Since both SK4 and TMEM16A require CAM . Current noise was small after excision of the patch in a Ca 2ϩ -containing bath solution (con), but it was activated in excised patches from mTMEM16A-expressing cells by adding ATP (3 mM) or calmodulin (1 g/ml) together with ATP to the cytosolic side (right panel). In contrast, no current is activated in an excised membrane patch from a mock-transfected cell (left panel). B, C) Current-voltage relationships measured in excised membrane patches obtained from mock-transfected (B) and mTMEM16A-expressing (C) cells, indicating current activation by ATP and calmodulin in mTMEM16A-expressing cells. Cells were voltage clamped from Ϫ50 to ϩ50 mV in steps of 10 mV. Means Ϯ se; n ϭ 7-9. Values in parentheses indicate n.
# P Ͻ 0.05; unpaired t test.
and ATP to be activated, we examined whether benzimidazolinone compounds are also able to activate TMEM16A. In excised mouse tracheas, 1-EBIO (50 M) activated a small and rather steady Cl Ϫ secretion and augmented ATP-activated short-circuit currents, apparently by activating both luminal TMEM16A and basolateral SK4 channels (Fig. 7A, B) . Notably, in the presence of the CFTR inhibitor CFTR inh 172 (5 M), 1-EBIO still augmented ATP-induced Cl Ϫ secretion (Fig. 7B) . In whole-cell patch-clamp experiments with human airway epithelial (Calu-3) cells, 1-EBIO and the related compound S0011198 increased whole-cell currents. However, in these cells, SK4 channels were activated by the benzimidazolones and hyperpolarized the membrane voltage, since Calu-3 cells do not express TMEM16A and do not have CaCCs (5) (Fig. 7C, D and Supplemental Fig. S3C ). When expressed in HEK293 cells, TMEM16A was activated by 1-EBIO (50 M) and riluzole (50 M), another known opener of SK4 channels (38) . Moreover, the related compound 5,6-dichloro-1-ethyl-1,3-dihydro2Hbenzimidazol-2-one (DCEBIO; 1 M) also activated TMEM16A (⌬Gϭ23.1Ϯ4.2 nS; nϭ5). In summary, both luminal Ca 2ϩ -activated TMEM16A and basolateral SK4 K ϩ channels are activated by the same compounds. Therefore, benzimidazolinones may be ideal drugs for the treatment of the lung disease CF, which is characterized by defective CFTR-dependent Cl Ϫ secretion and dehydration of the airways (39 -41) .
DISCUSSION
Activation of membrane-localized TMEM16A
In the present study, we examined the mechanisms for activation of the novel Ca 2ϩ -activated Cl Ϫ channel TMEM16A and identified pharmacological properties that allow interfering with the activity of this highly relevant channel. The data demonstrate that TMEM16A is membrane localized and is activated by Ca 2ϩ in an actin-dependent manner. Notably, a contribution of the actin cytoskeleton to activation of endogenous CaCCs in epithelial cells has been suggested earlier (42) . We found no evidence for a role of exocytosis in activating TMEM16A, and thus confirm earlier data from pancreatic acinar cells, showing exocytosis-independent activation of ion channels due to spatial distribution of cytosolic Ca 2ϩ (43) . Similar to other epithelial ion channels, anchoring of TMEM16A to the cytoskeleton and to membrane PIP 2 may be essential to maintain channel activity (44, 45) . A regulatory link between endogenous CaCCs, actin cyto- skeleton, and actin-bound annexin IV has been detected earlier in colonic carcinoma cells (29) .
CAMKII, calmodulin, and ATP
Initial studies demonstrated activation of TMEM16A by an increase in cytosolic Ca 2ϩ , but they did not present evidence for a requirement of cytosolic ATP (2, 3). We found that the presence of the ATP-cleaving enzyme apyrase in the pipette solution largely reduced channel activity, suggesting a requirement of ATP for full activation of TMEM16A. Some properties of TMEM16A are clearly different from those found for endogenous CaCCs in epithelial cells. First, TMEM16A expressed in HEK293 and FRT cells (6) is partially active at basal intracellular Ca 2ϩ concentrations, while endogenous CaCCs are closed under control conditions. Second, CAMKII inhibited TMEM16A currents expressed in HEK293 cells, but it activates endogenous CaCCs in colonic, airway, and pancreatic epithelial cells (8, 29 -31) . Notably, regulation of CaCCs by CAMKII is celltype dependent, and inhibition of CaCCs by CAMKII has been described for smooth muscle cells (25, 26) . Preliminary experiments also indicate that overexpressed TMEM16A is inhibited by CAMKII, while activation of endogenous CaCCs in CFPAC-1 cells is CAMKII dependent (data not shown). However, CFPAC-1 cells express TMEM16A endogenously, and siRNA knockdown of TMEM16A inhibits CaCCs, indicating that TMEM16A is a crucial component of the endogenous CaCCs. It is, therefore, likely that the cellular environment and/or additional auxiliary proteins determine CAMKII-dependent regulation (5) .
The present data demonstrate that calmodulin is one of the auxiliary proteins necessary for activation of TMEM16A. According to the present data, the putative site for calmodulin binding overlaps with segment b of the splice form abc of TMEM16A (Fig. 4A) . We found reduced activity of ac-TMEM16A compared with abc-TMEM16A, which is actually different from the results of a previous study (4) . This discrepancy remains unexplained. However, in preliminary experiments, we found that intracellular Ca 2ϩ itself triggers inactivation of the channel, and inactivation of ac-TMEM16A occurs at lower [Ca 2ϩ ] i than for abc-TMEM16A (unpublished data). Also, it appears possible that Ca 2ϩ and calmodulin have more than one binding site. In overexpressing cells, additional accessory proteins may still be missing to produce a "complete" chloride channel complex. In preliminary experiments, we performed 2-hybrid screening using the split ubiquitin system in order to identify additional interacting partners, and identified the Ca 2ϩ -binding protein S100A11. However siRNA knockdown of S100/A11 did not change TMEM16A currents.
Similar mechanisms for activation of SK4 and TMEM16A
Calmodulin regulation of TMEM16A is reminiscent of Ca 2ϩ /calmodulin-dependent regulation of SK4 (KCNN4) potassium channels. The open probability of SK4/IK1 channels is tightly regulated by cytosolic Ca 2ϩ concentrations in the range between 100 and 1000 nM, although typical Ca 2ϩ binding domains are not present in SK4. The pronounced Ca 2ϩ sensitivity of SK4 is due to its high affinity for calmodulin (32-34, 46 -49) . Activation of SK4/IK1 by the benzimidazolinone 1-EBIO is well established and is due to enhanced Ca 2ϩ sensitivity of the CAM/SK4 channel complex (37, 50 -52). 1-EBIO has also been shown to activate apical Cl Ϫ channels of unknown molecular identity in rabbit conjunctival epithelium and intestinal epithelium (53, 54) . However most studies claim that activation of Cl Ϫ secretion by 1-EBIO is indirect, by increasing the driving force due to activation of basolateral SK4 channels (50, 55) . In this regard, a derivative of 1-EBIO, DCEBIO, was very potent in activating K ϩ channels and on top activated an unknown apical membrane Cl Ϫ conductance in monolayers of T 84 colonic carcinoma cells (56) .
We found that 1-EBIO, DCEBIO, and riluzole activated TMEM16A. An exciting finding was that only low concentrations of these compounds were required to activate TMEM16A (Supplemental Fig. S3 ). While typically 0.1-1 mM of 1-EBIO is required to activate SK4, TMEM16A was activated at concentrations as low as 1 M. Despite the complex Ca 2ϩ -dependent regulation of TMEM16A outlined above, activation by 1-EBIO, DCEBIO, and riluzole was robust and was observed for overexpressed TMEM16A as well as endogenous CaCCs in CFPAC-1 cells (Supplemental Fig. S3 ).
Since benzimidazolinones activate both basolateral SK4 and luminal TMEM16A channels, they could be ideal compounds for the treatment of the lung disease CF. As cAMP-dependent Cl Ϫ secretion is defective in CF, Ca 2ϩ -dependent Cl Ϫ secretion may compensate for the defect in CFTR-function. It will be exciting to search for more potent activators of both TMEM16A and SK4. Since pharmacological properties of Ca 2ϩ -activated Cl Ϫ and K ϩ channels appear to overlap considerably (57), it will also be interesting to learn whether pharmacological properties of TMEM16A are altered by factors such as CAMKII, ATP, or histidinephosphorylation, as described for SK4 channels (59, 59) . As TMEM16A is broadly expressed in a number of tissues, it may become a highly relevant drug target in the future.
